Nautilus Biotechnology, Inc. (NAUT) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $1.28M | -39.8% |
| 2024 | $2.12M | -13.1% |
| 2023 | $2.44M | +5.1% |
| 2022 | $2.32M | +2.4% |
| 2021 | $2.27M | +146.4% |
| 2020 | $921.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $1.28M | -39.8% |
| 2024 | $2.12M | -13.1% |
| 2023 | $2.44M | +5.1% |
| 2022 | $2.32M | +2.4% |
| 2021 | $2.27M | +146.4% |
| 2020 | $921.0K | — |